Table 4. Results of multivariate analysis of OS.
| Variables | HR | 95% CI | P-value | |
|---|---|---|---|---|
| Sex | 1.056 | 0.808–1.381 | 0.689 | |
| T stage | ||||
| T1 | Ref. | <0.001 | ||
| T2 | 1.568 | 1.054–2.332 | 0.026 | |
| T3 | 1.258 | 0.864–1.831 | 0.232 | |
| T4 | 2.642 | 1.785–3.910 | <0.001 | |
| N stage | ||||
| N0 | Ref. | <0.001 | ||
| N1 | 1.607 | 1.124–2.297 | 0.009 | |
| N2 | 2.758 | 1.804–4.219 | <0.001 | |
| N3 | 3.675 | 2.429–5.560 | <0.001 | |
| LNR stage | ||||
| LNR0 | Ref. | <0.001 | ||
| LNR1 | 1.583 | 1.119–2.241 | 0.009 | |
| LNR2 | 3.514 | 2.425–5.094 | <0.001 | |
| LNR3 | 10.261 | 4.867–21.633 | <0.001 | |
OS = overall survival; LNR = lymph node ratio; HR = hazard ratio; CI = confidence interval.